EZH2 is crucial for both differentiation of regulatory T cells and T effector cell expansion-Reference-Cited by-同舟云学术

EZH2 is crucial for both differentiation of regulatory T cells and T effector cell expansion

Published:2015-06-19 Issue:1 Volume:5 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Yang Xiang-Ping,Jiang Kan,Hirahara Kiyoshi,Vahedi Golnaz,Afzali Behdad,Sciume Giuseppe,Bonelli Michael,Sun Hong-Wei,Jankovic Dragana,Kanno Yuka,Sartorelli Vittorio,O’Shea John J.,Laurence Arian

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep10643.pdf

Reference33 articles.

1. O’Shea, J. J. & Paul, W. E. Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 327, 1098–1102,(2010).

2. Zhu, J., Yamane, H. & Paul, W. E. Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol 28, 445–489,(2010).

3. Kanno, Y., Vahedi, G., Hirahara, K., Singleton, K. & O’Shea, J. J. Transcriptional and epigenetic control of T helper cell specification: molecular mechanisms underlying commitment and plasticity. Annu Rev Immunol 30, 707–731.

4. Mukasa, R. et al. Epigenetic instability of cytokine and transcription factor gene loci underlies plasticity of the T helper 17 cell lineage. Immunity 32, 616–627,(2010).

5. Floess, S. et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol 5, e38,(2007).

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infiltrating treg reprogramming in the tumor immune microenvironment and its optimization for immunotherapy;Biomarker Research;2024-09-04

2. Lysine methylation modifications in tumor immunomodulation and immunotherapy: regulatory mechanisms and perspectives;Biomarker Research;2024-07-30

3. Targeting cytotoxic lymphocyte antigen 4 (CTLA-4) in breast cancer;European Journal of Medical Research;2024-07-02

4. EZH2: The roles in targeted therapy and mechanisms of resistance in breast cancer;Biomedicine & Pharmacotherapy;2024-06

5. PROTAC EZH2 degrader-1 overcomes the resistance of podophyllotoxin derivatives in refractory small cell lung cancer with leptomeningeal metastasis;BMC Cancer;2024-04-22